Meta-analysia of combining rh-endostatin with chemotherapy in treatment of patients with nsclc

• In: Pharmacoepidemiology/Pharmacoeconomics Posters
• At: Lisbon (Portugal) (2010)
• Type: Poster
• Poster code: PP-P-005
• By: CHEN, Baicheng (The 303 Hospital of PLA, China, Nanning, China)
• Co-author(s): Zhang, Qi (The 303 Hospital of PLA, China, NANNING, China)
  Xia, Aijun (The 303 Hospital of PLA, China, NANNING, China)
  
• Abstract:

  Objective In order to evaluate the efficacy of combining rh-endostatin with Chemo- therapy for non-small cell lung cancer(NSCLC) compared with chemotherapy alone. Methods The randomized clinical trials(RCTs) that compared the efficacy of combining rh-endostatin with Chemotherapy and chemotherapy alone form 2000 to 2004. A meta-analysis was..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login